| 1. |
News in brief … |
| |
PharmacoResources,
Volume &NA;,
Issue 3,
1994,
Page 2-2
&NA;,
Preview
|
PDF (711KB)
|
|
ISSN:1172-8299
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 2. |
Pharmacoeconomics as a tool - methodologies and applications |
| |
PharmacoResources,
Volume &NA;,
Issue 3,
1994,
Page 3-4
Nancy JW Lewis,
Preview
|
PDF (1370KB)
|
|
摘要:
In this era of healthcare cost containment and outcomes assessment, measuring and obtaining the greatest value possible from healthcare services and products is paramount. While there is debate about the value of certain medical procedures, pharmaceuticals are typically viewed as providing a definite health benefit. This view is due, in part, to the requirement that pharmaceuticals meet regulatory standards for efficacy and safety prior to marketing.
ISSN:1172-8299
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 3. |
Aim for a cost-effective formulary |
| |
PharmacoResources,
Volume &NA;,
Issue 3,
1994,
Page 5-5
&NA;,
Preview
|
PDF (654KB)
|
|
ISSN:1172-8299
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 4. |
Converging or diverging healthcare systems? - looking at the UK & US |
| |
PharmacoResources,
Volume &NA;,
Issue 3,
1994,
Page 6-6
&NA;,
Preview
|
PDF (741KB)
|
|
ISSN:1172-8299
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 5. |
GP treatment could halve costs of nail infection |
| |
PharmacoResources,
Volume &NA;,
Issue 3,
1994,
Page 7-7
&NA;,
Preview
|
PDF (705KB)
|
|
ISSN:1172-8299
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 6. |
Risperidonedoes it give enough bang for the buck? |
| |
PharmacoResources,
Volume &NA;,
Issue 3,
1994,
Page 8-9
Greg L Plosker,
Preview
|
PDF (1424KB)
|
|
摘要:
Risperidone is expensive but, apparently, nottooexpensive. Recent Canadian guidelines suggest a cut-off point for how much spending can be justified per quality-adjusted life-year (QALY) gained when comparing old treatments with new. And a recent cost-utility study conducted by Janssen researchers has determined that risperidone comes close enough to this cut-off point to be recommended as treatment for schizophrenia. The results of this study were discussed at the 20th Annual Canadian Society of Hospital Pharmacists (Western Branches) [Banff, Alberta, Canada; March 1994].
ISSN:1172-8299
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 7. |
Cost considerations … |
| |
PharmacoResources,
Volume &NA;,
Issue 3,
1994,
Page 9-9
&NA;,
Preview
|
PDF (696KB)
|
|
ISSN:1172-8299
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 8. |
Directedvsblind MMR immunisation? |
| |
PharmacoResources,
Volume &NA;,
Issue 3,
1994,
Page 10-11
&NA;,
Preview
|
PDF (1382KB)
|
|
ISSN:1172-8299
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 9. |
QOL measures essential in cancer treatment |
| |
PharmacoResources,
Volume &NA;,
Issue 3,
1994,
Page 11-12
&NA;,
Preview
|
PDF (1411KB)
|
|
ISSN:1172-8299
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 10. |
Lessons learned from cancer QOL |
| |
PharmacoResources,
Volume &NA;,
Issue 3,
1994,
Page 12-12
&NA;,
Preview
|
PDF (750KB)
|
|
ISSN:1172-8299
出版商:ADIS
年代:1994
数据来源: ADIS
|
首页
